Posts with tag Orphan medicine

This article is part of a series that covers the proposed reforms to EU pharmaceutical legislation. To view our first article and the whole series, please click here. As part of the revision of the EU pharmaceutical legislative framework, a new regulation is proposed, which will replace, among others, Regulation (EU) 141/2000 on orphan medicinal products. According to the European Commission, the current legislation on orphan medicinal products no longer meets the needs of both...